NCT03883321

Brief Summary

The CBSM is a program combining cognitive and behavioral therapies, relaxation provided in groups of 8 to 10 patients. This program has demonstrated benefits in stress management skills, adaptive strategies, anxiety, quality of life, social inclusion, medication adherence, depression, therapeutic alliance, and general well-being. It would also improve breast cancer survival after adjuvant therapy. This program has been put in place at the center of pain for patients with cancer pain in any stage. This study aims to evaluate the benefits of this technique on a patient population suffering from chronic pain related to cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 20, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

September 2, 2020

Status Verified

August 1, 2020

Enrollment Period

1.4 years

First QC Date

January 15, 2019

Last Update Submit

August 31, 2020

Conditions

Keywords

stress managementCBSMChronic PainCancer

Outcome Measures

Primary Outcomes (1)

  • Measurement of emotional stress (PSS14)

    assessment of the evolution of stress over a period of 3 months: Questionnaire PSS14

    evaluation at the beginning of the meeting and at 9 weeks

Secondary Outcomes (6)

  • Inclusion rate

    up to 18 months

  • Satisfaction

    at 6 months

  • Measurement of quality of life

    evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  • Pain Disability Index (PDI)

    evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  • concise questionnaire on pain short version (QCD)

    evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  • +1 more secondary outcomes

Study Arms (2)

CBSM

Patients included in this group participate in the CBSM program. They attend 10 sessions of stress management according to the CBSM program, 9 take place over 3 months and the tenth session takes place 3 months after the 9th session. The session is composed of relaxation and cognitive and behavioral therapy, which is carried out in groups of 8 to 10 patients

Other: Cognitive behavioral stress management

Waiting list

The CBSM group is compared to the "waiting list" group that does not benefit from the CBSM program. After completing their assessment in the "waiting list" group, patients in this group will be integrated into the CBSM group but will not be evaluated as such.

Interventions

Management of patients in 10 group sessions with cognitive and behavioral therapies associated with relaxation in order to learn how to manage stress

CBSM

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient being treated for cancer, undergoing treatment or having completed treatment, at any stage and suffering from chronic pain

You may qualify if:

  • Over 18,
  • Currently treated or treated for cancer (solid or otherwise), any stage combined.
  • With chronic pain related to cancer or its treatment
  • Never benefited from the management of stress by this technique
  • Knowing how to read, write and speak French
  • Person affiliated with social security or beneficiary of an equivalent plan.

You may not qualify if:

  • Life expectancy of less than 6 months
  • Patients unable to travel for 10 sessions on the structure
  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grenoble University Hospital

La Tronche, Isère, 30700, France

Location

MeSH Terms

Conditions

Chronic PainNeoplasms

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Claudine BERTHOZAT, MD

    pain center, Grenoble University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2019

First Posted

March 20, 2019

Study Start

September 1, 2018

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

September 2, 2020

Record last verified: 2020-08

Locations